9280
S. A. Ivanov et al. / Tetrahedron 60 (2004) 9273–9281
(both isomers) (n-C6H14/AcOEt/Et3N, 5:25:2.4, v/v). 1H
NMR (CDCl3): dZ7.58 (s, 1H, H–C6), 7.33–7.15 (m, 9H,
H-phenyl), 6.75 (d, 4H, H-phenyl), 6.39 (m, 1H, H–C10),
4.52 (m, 1H, H–C30), 4.02 (m, 1H, H–C40), 3.99 (t, 2H,
CH2-Lev), 3.73, 3.72 (ss, 6H, CH3O), 3.51–3.42 (m, 4H,
CH2; 2H, CH2OP, 2H H–C i-Pr), 3.22 (m, 2H, H–C50),
2.70–2.66 (m, 2H, CH2-Lev), 2.56–2.47 (m, 1H, Ha-C20;
1H, H–CHCN), 2.31 (t, 1H, H–CHCN), 2.18 (m, 1H,
Hb-C20), 2.12 (s, 3H, CH3-Lev), 1.55 (m, 4H, CH2), 1.37 (s,
3H, CH3-C5), 1.30 (m, 4H, CH2), 1.22–0.93 (m, 12H, CH3
i-Pr). 13C NMR (CDCl3): dZ206.8 (Me–CO), 172.8
(O–CO), 163.1 (C4), 158.6 (C phenyl), 156.2 (C2), 144.4
(C phenyl), 137.1 (C6), 135.5 (C phenyl), 130.2–127.0 (CH
phenyl), 117.6 (CH2CN), 113.3–113.2 (CH phenyl), 101.7
(C5), 86.6, 85.5 (Cq, C10,C40), 72.1 (C30), 64.5 (C50), 58.1
(CH2OP), 55.3 (OCH3), 46.9 (C20), 45.7 (CH2-linker), 43.2
(CH2CN), 40.9 (CH2-linker), 37.9 (CH2-Lev), 29.9, 29.2
(CH2-linker), 28.5 (CH3-Lev), 28.0 (CH2-Lev), 26.4, 25.6
(2CH2-linker), 24.7–24.5 (CH-iPr), 20.1–19.4 ((CH3)2iPr),
12.4 (CH3–C5). 31P NMR (CDCl3): dZ150.1, 149.5.
FAB-MS, m/z: Calcd (MCNaC) 965.10, found 965.03
(MZC51H68O10N5P).
cytosine, dimethylformamidine with guanine. Unmodified
phosphoramidites were coupled using the standard proto-
col.30 For coupling of the branching nucleotide the
following changes to the protocol were made: a 40-fold
excess of phosphoramidite over the solid phase was used
and the coupling time was extended from 5 to 24 min. The
coupling reaction was carried out in two steps: first, 100 ml
of the 0.2 M phosphoramidite solution were cycled over the
column and coupling was allowed to proceed for 12 min.
Immediately after this, the same amount of fresh phosphor-
amidite solution was transferred to the column and the
coupling reaction was extended for another 12 min. The
following nucleotides (segment B) were coupled without
changes to the standard protocol. Prior to synthesis of
segment C (see Figs. 2 and 4), the terminal 50-OH group of
segment B was acetylated by treating the polymer support
manually five times with 100 ml Capping A solution (Ac2O
in pyridine) and 100 ml Capping B solution (1-methylimi-
dazole in pyridine), each turn taking 3 s. The column was
washed thoroughly with acetonitrile (5 ml), then removed
from the synthesizer and treated with 6 ml of a freshly
prepared solution of 0.5 M hydrazine hydrate in pyridine/
acetic acid (4:1, v/v) for 5 min (solution was slowly passed
through the column using a syringe). The column again was
washed thoroughly with anhydrous acetonitrile (7 ml) and
transferred back to the synthesizer. Assembly of segment C
was carried out again following the standard protocol.
4.3. RNA synthesis
Oligoribonucleotides were synthesized by the phosphor-
amidite method essentially as described previously.3,30 An
automated DNA/RNA synthesizer (Gene Assembler Special,
Pharmacia) was used for chain assembly at a 1 mmol scale.
Fluorescein labelled RNA substrates (S14F5, S24F5 and
30
˚
S36F5) were synthesized on CPG 500 A, as described.
AAAAAK
CGUGK
The model oligoribonucleotide SI-SLA5 (
XAAðdTÞ
˚
Deblocking was performed using saturated methanolic
ammonia for 22 h at 25 8C with the branched RNAs SI-
SLA5 and HP-RJTLB or over 12 h at ambient temperature
with substrate RNAs S14F5, S24F5 and S36F5. Removal of
the 20-O-silyl-protecting groups was achieved by treating
the samples with triethylamine trihydrofluoride in DMF
(3:1, v/v, 0.8 ml) for 1.5 h at 55 8C. The reaction was
quenched by addition of water (0.2 ml) and the RNA chains
were precipitated from n-butanol.
with XZ4-triazolo-dT), was synthesized on a 500 A CPG
support. The modified phosphoramidite 2 was dissolved in
dry acetonitrile to give a 0.12 M concentration and filtered
through 0.45 mm Teflon filters prior to use. Synthesis was
performed ‘trityl off’. Phenoxyacetyl groups were used for
protection of the amino functions of adenine, cytosine and
guanine. Unmodified phosphoramidites were coupled using
the standard protocol.30 The coupling time for 2 was
extended from 5 min (standard protocol) to 10 min. The
following nucleotides CGUG were coupled without changes
to the standard protocol. Prior to synthesis of the side-chain
(A)5, the terminal 50-OH group of the main-chain was
acetylated by manually treating the polymer support five
times with 100 ml Capping A solution (Ac2O in pyridine)
and 100 ml Capping B solution (1-methylimidazole in
pyridine), each turn taking 10 s. The column was washed
thoroughly with acetonitrile (5 ml), then removed from the
synthesizer and treated with 10 ml of a freshly prepared
solution of 0.33 M aminohexanol in acetonitrile for 45 min
(solution was slowly passed through the column using a
syringe). The column again was washed thoroughly with
anhydrous acetonitrile (10 ml), transferred back to the
synthesizer and washed again with anhydrous acetonitrile
(5 ml). Assembly of the side-chain was carried out
following the standard protocol.
The branched RNAs were purified by 20% denaturing (7 M
urea) PAGE (acrylamide/bis-acrylamide 19:1) on 8!10 cm
glass plates at 60 8C in TBE buffer at 100 V. The gel was
soaked in ethidium bromide solution; visualization of RNA
was achieved by irradiation with UV-light (254 nm). The
band corresponding to the desired product was excised from
the gel and eluted with 2 M LiClO4 overnight at room
temperature. The oligonucleotide then was precipitated
from acetone. Fluorescein labelled RNA substrates were
purified using 20% denaturing polyacrylamide gels. Bands
corresponding to the desired products were visualized both
at 254 and 366 nm, excised from the gel and treated as
described above.
4.4. Nucleoside composition analysis
For synthesis of the branched ribozyme HP-RJTLB, CPG
˚
with a pore size of 1000 A was used. The branching
nucleotide building block 3 was dissolved in dry acetonitrile
at a concentration of 0.2 M and filtered through 0.45 mm
Teflon filters prior to use. Synthesis was performed ‘trityl
off’. Benzoyl was used for N-protection with adenine and
Oligoribonucleotides (0.08 O.D.260) were dissolved in 10 ml
of nuclease P1 buffer (40 mM AcONa, 2 mM (AcO)2Zn pH
5.3) and a freshly prepared solution of nuclease P1 from
Penicillium citrinum in the same buffer (10 ml, 10 mg/ml)
was added. After incubation at 37 8C for 12 h, 10!
dephosphorylation buffer (4 ml), alkaline phosphatase from